{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T23:22:31Z","timestamp":1791501751342,"version":"4.3.4"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,11]],"date-time":"2022-03-11T00:00:00Z","timestamp":1646956800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.ebiom.2022.103967","type":"journal-article","created":{"date-parts":[[2022,3,26]],"date-time":"2022-03-26T22:46:19Z","timestamp":1648334779000},"page":"103967","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["T cell response against SARS-CoV-2 persists after one year in patients surviving severe COVID-19"],"prefix":"10.1016","volume":"78","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0462-4235","authenticated-orcid":false,"given":"Fabienne","family":"Venet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgane","family":"Gossez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Bidar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8691-385X","authenticated-orcid":false,"given":"Maxime","family":"Bodinier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9my","family":"Coudereau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9372-1533","authenticated-orcid":false,"given":"Anne-Claire","family":"Lukaszewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Tardiveau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Brengel-Pesce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Cheynet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3605-185X","authenticated-orcid":false,"given":"Marie-Ang\u00e9lique","family":"Cazalis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9mi","family":"Pescarmona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorna","family":"Garnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marine","family":"Ortillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marielle","family":"Buisson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maude","family":"Bouscambert-Duchamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Morfin-Sherpa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-S\u00e9bastien","family":"Casalegno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Conti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Rimmel\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Argaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Cour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitra","family":"Saadatian-Elahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laetitia","family":"Henaff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Vanhems","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Monneret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ebiom.2022.103967_bib0001","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/S2213-2600(21)00218-6","article-title":"The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity","volume":"9","author":"Osuchowski","year":"2021","journal-title":"Lancet Respir Med"},{"issue":"1","key":"10.1016\/j.ebiom.2022.103967_bib0002","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s13054-021-03558-w","article-title":"Longitudinal assessment of IFN-I activity and immune profile in critically ill COVID-19 patients with acute respiratory distress syndrome","volume":"25","author":"Venet","year":"2021","journal-title":"Crit Care"},{"issue":"17","key":"10.1016\/j.ebiom.2022.103967_bib0003","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.140329","article-title":"Severe immunosuppression and not a cytokine storm characterizes COVID-19 infections","volume":"5","author":"Remy","year":"2020","journal-title":"JCI Insight"},{"issue":"10","key":"10.1016\/j.ebiom.2022.103967_bib0004","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-039088","article-title":"Protocol for a prospective, observational, hospital-based multicentre study of nosocomial SARS-CoV-2 transmission: NOSO-COR Project","volume":"10","author":"Saadatian-Elahi","year":"2020","journal-title":"BMJ Open"},{"issue":"6","key":"10.1016\/j.ebiom.2022.103967_bib0005","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/cyto.b.21360","article-title":"Evaluation of a novel automated volumetric flow cytometer for absolute CD4+ T lymphocyte quantitation","volume":"92","author":"Gossez","year":"2017","journal-title":"Cytom B Clin Cytom"},{"issue":"1","key":"10.1016\/j.ebiom.2022.103967_bib0006","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/cyto.b.21043","article-title":"Inter-laboratory assessment of flow cytometric monocyte HLA-DR expression in clinical samples","volume":"84","author":"Demaret","year":"2013","journal-title":"Cytom B Clin Cytom"},{"issue":"6","key":"10.1016\/j.ebiom.2022.103967_bib0007","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9061871","article-title":"Performance assessment of SARS-CoV-2 PCR assays developed by WHO referral laboratories","volume":"9","author":"Etievant","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.ebiom.2022.103967_bib0008","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jim.2014.10.006","article-title":"Flow cytometric evaluation of lymphocyte transformation test based on 5-ethynyl-2\u2032deoxyuridine incorporation as a clinical alternative to tritiated thymidine uptake measurement","volume":"415","author":"Poujol","year":"2014","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.ebiom.2022.103967_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103622","article-title":"Severe COVID-19 is characterized by the co-occurrence of moderate cytokine inflammation and severe monocyte dysregulation","volume":"73","author":"Bonnet","year":"2021","journal-title":"EBioMedicine"},{"issue":"9","key":"10.1016\/j.ebiom.2022.103967_bib0010","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S2213-2600(20)30316-7","article-title":"Case characteristics, resource use, and outcomes of 10 021 patients with COVID-19 admitted to 920 German hospitals: an observational study","volume":"8","author":"Karagiannidis","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.ebiom.2022.103967_bib0011","article-title":"Immune profiling demonstrates a common immune signature of delayed acquired immunodeficiency in patients with various etiologies of severe injury","author":"Venet","year":"2021","journal-title":"Crit Care Med"},{"issue":"1","key":"10.1016\/j.ebiom.2022.103967_bib0012","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s00134-020-06294-x","article-title":"Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study","volume":"47","year":"2021","journal-title":"Intensive Care Med"},{"issue":"9","key":"10.1016\/j.ebiom.2022.103967_bib0013","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/s41577-020-0402-6","article-title":"T cell responses in patients with COVID-19","volume":"20","author":"Chen","year":"2020","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"10.1016\/j.ebiom.2022.103967_bib0014","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1007\/s00134-020-06123-1","article-title":"Coronavirus disease 2019 as a particular sepsis: a 2-week follow-up of standard immunological parameters in critically ill patients","volume":"46","author":"Monneret","year":"2020","journal-title":"Intensive Care Med"},{"issue":"9","key":"10.1016\/j.ebiom.2022.103967_bib0015","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1007\/s00134-020-06127-x","article-title":"Severe COVID-19 is associated with deep and sustained multifaceted cellular immunosuppression","volume":"46","author":"Jeannet","year":"2020","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.ebiom.2022.103967_bib0016","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s40560-020-00453-4","article-title":"Lymphopenia in severe coronavirus disease-2019 (COVID-19): systematic review and meta-analysis","volume":"8","author":"Huang","year":"2020","journal-title":"J Intensive Care"},{"issue":"54","key":"10.1016\/j.ebiom.2022.103967_bib0017","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abe0240","article-title":"Defining the features and duration of antibody responses to SARS-CoV-2 infection associated with disease severity and outcome","volume":"5","author":"Roltgen","year":"2020","journal-title":"Sci Immunol"},{"issue":"1","key":"10.1016\/j.ebiom.2022.103967_bib0018","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41590-020-00826-9","article-title":"Distinct antibody responses to SARS-CoV-2 in children and adults across the COVID-19 clinical spectrum","volume":"22","author":"Weisberg","year":"2021","journal-title":"Nat Immunol"},{"issue":"12","key":"10.1016\/j.ebiom.2022.103967_bib0019","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1038\/s41564-020-00813-8","article-title":"Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans","volume":"5","author":"Seow","year":"2020","journal-title":"Nat Microbiol"},{"issue":"8","key":"10.1016\/j.ebiom.2022.103967_bib0020","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.arcmed.2021.08.005","article-title":"Seroconversion in septic ICU patients presenting with COVID-19: necessary but not sufficient","volume":"52","author":"Conti","year":"2021","journal-title":"Arch Med Res"},{"issue":"6529","key":"10.1016\/j.ebiom.2022.103967_bib0021","doi-asserted-by":"crossref","DOI":"10.1126\/science.abf4063","article-title":"Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection","volume":"371","author":"Dan","year":"2021","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.ebiom.2022.103967_bib0022","first-page":"281","article-title":"Persistence of SARS-CoV-2-specific B and T cell responses in convalescent COVID-19 patients 6-8 months after the infection","volume":"2","author":"Sherina","year":"2021","journal-title":"Med (N Y)"},{"issue":"6","key":"10.1016\/j.ebiom.2022.103967_bib0023","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1128\/CDLI.7.6.859-864.2000","article-title":"New methods for assessing T-cell responses","volume":"7","author":"Bercovici","year":"2000","journal-title":"Clin Diagn Lab Immunol"},{"issue":"1","key":"10.1016\/j.ebiom.2022.103967_bib0024","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1038\/s41467-021-21856-3","article-title":"T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiviral responses","volume":"12","author":"Ogbe","year":"2021","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.ebiom.2022.103967_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.103743","article-title":"Immunity to SARS-CoV-2 up to 15 months after infection","volume":"25","author":"Marcotte","year":"2022","journal-title":"iScience."},{"issue":"7","key":"10.1016\/j.ebiom.2022.103967_bib0026","article-title":"Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells","volume":"2","author":"Cohen","year":"2021","journal-title":"Cell Rep Med"},{"issue":"4 Suppl","key":"10.1016\/j.ebiom.2022.103967_bib0027","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1038\/nm1212","article-title":"T cell vaccines for microbial infections","volume":"11","author":"Robinson","year":"2005","journal-title":"Nat Med"},{"issue":"2 Suppl 2","key":"10.1016\/j.ebiom.2022.103967_bib0028","doi-asserted-by":"crossref","first-page":"S182","DOI":"10.1016\/j.jaci.2009.07.053","article-title":"Primary immunodeficiencies","volume":"125","author":"Notarangelo","year":"2010","journal-title":"J Allergy Clin Immunol"},{"issue":"Suppl 2","key":"10.1016\/j.ebiom.2022.103967_bib0029","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13223-018-0290-5","article-title":"Primary immunodeficiency","volume":"14","author":"McCusker","year":"2018","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"590","key":"10.1016\/j.ebiom.2022.103967_bib0030","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abf7517","article-title":"T cell and antibody kinetics delineate SARS-CoV-2 peptides mediating long-term immune responses in COVID-19 convalescent individuals","volume":"13","author":"Bilich","year":"2021","journal-title":"Sci Transl Med"},{"issue":"1","key":"10.1016\/j.ebiom.2022.103967_bib0031","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41590-020-00838-5","article-title":"Deciphering the ins and outs of SARS-CoV-2-specific T cells","volume":"22","author":"Perez-Potti","year":"2021","journal-title":"Nat Immunol"},{"issue":"7","key":"10.1016\/j.ebiom.2022.103967_bib0032","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.cell.2020.05.015","article-title":"Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals","volume":"181","author":"Grifoni","year":"2020","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.ebiom.2022.103967_bib0033","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1038\/s41467-021-24377-1","article-title":"SARS-CoV-2-specific T cell memory is sustained in COVID-19 convalescent patients for 10 months with successful development of stem cell-like memory T cells","volume":"12","author":"Jung","year":"2021","journal-title":"Nat Commun"},{"issue":"6","key":"10.1016\/j.ebiom.2022.103967_bib0034","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/s41577-021-00550-x","article-title":"Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection","volume":"21","author":"Cromer","year":"2021","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"10.1016\/j.ebiom.2022.103967_bib0035","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/s41467-021-21111-9","article-title":"Rapid decline of neutralizing antibodies against SARS-CoV-2 among infected healthcare workers","volume":"12","author":"Marot","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.ebiom.2022.103967_bib0036","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.100734","article-title":"Antibody titers against SARS-CoV-2 decline, but do not disappear for several months","volume":"32","author":"Yamayoshi","year":"2021","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.ebiom.2022.103967_bib0037","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.cyto.2016.08.003","article-title":"TNF activity and T cells","volume":"101","author":"Mehta","year":"2018","journal-title":"Cytokine"},{"key":"10.1016\/j.ebiom.2022.103967_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103230","article-title":"SARS-CoV-2 persistence is associated with antigen-specific CD8 T-cell responses","volume":"64","author":"Vibholm","year":"2021","journal-title":"EBioMedicine"},{"issue":"9","key":"10.1016\/j.ebiom.2022.103967_bib0039","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/s41423-020-0516-6","article-title":"Immune monitoring of interleukin-7 compassionate use in a critically ill COVID-19 patient","volume":"17","author":"Monneret","year":"2020","journal-title":"Cell Mol Immunol"},{"issue":"10","key":"10.1016\/j.ebiom.2022.103967_bib0040","doi-asserted-by":"crossref","first-page":"5710","DOI":"10.1002\/jmv.27172","article-title":"Immunostimulation with interferon-gamma in protracted SARS-CoV-2 pneumonia","volume":"93","author":"Lukaszewicz","year":"2021","journal-title":"J Med Virol"},{"issue":"10","key":"10.1016\/j.ebiom.2022.103967_bib0041","first-page":"1163","article-title":"Interferon gamma immunotherapy in five critically ill COVID-19 patients with impaired cellular immunity: a case series","volume":"2","author":"van Laarhoven","year":"2021","journal-title":"Med (N Y)"},{"issue":"7","key":"10.1016\/j.ebiom.2022.103967_bib0042","first-page":"e0500","article-title":"Interleukin-7 reverses lymphopenia and improves T-cell function in coronavirus disease 2019 patient with inborn error of toll-like receptor 3: a case report","volume":"3","author":"Mazer","year":"2021","journal-title":"Crit Care Explor"},{"issue":"1","key":"10.1016\/j.ebiom.2022.103967_bib0043","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s41591-021-01643-9","article-title":"A guide to immunotherapy for COVID-19","volume":"28","author":"van de Veerdonk","year":"2022","journal-title":"Nat Med"},{"issue":"6","key":"10.1016\/j.ebiom.2022.103967_bib0044","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1056\/NEJMoa2034545","article-title":"Antibody status and incidence of SARS-CoV-2 infection in health care workers","volume":"384","author":"Lumley","year":"2021","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.ebiom.2022.103967_bib0045","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1016\/j.jinf.2020.12.023","article-title":"Prior SARS-CoV-2 infection is associated with protection against symptomatic reinfection","volume":"82","author":"Hanrath","year":"2021","journal-title":"J Infect"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396422001517?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396422001517?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:18:02Z","timestamp":1762456682000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396422001517"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":45,"alternative-id":["S2352396422001517"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2022.103967","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"T cell response against SARS-CoV-2 persists after one year in patients surviving severe COVID-19","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2022.103967","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103967"}}